远程细胞病理学在快速现场评估细针穿刺活检中的临床研究进展

Clinical research progress of telecytopathology in rapid on-site evaluation of fine needle aspiration biopsy

快速现场评估(ROSE)能够及时地反馈细针穿刺活检(FNAB)组织的充足性和有效性,已广泛应用于甲状腺、淋巴结等组织的取材活检中,但ROSE技术需要病理医师出现在活检现场,这限制了其在各地医院的开展。远程细胞病理学(TCP)通过实时传输组织病理图像,实现病理医师和活检操作医师间的实时交流,使得没有病理医师在场的情况下也能开展现场评估。目前TCP现场评估在国外得到了较广泛的开展,而国内研究很少,为此,本文综述了目前TCP现场评估在各种病理组织中的应用研究进展,以及广泛开展TCP现场评估仍存在的阻碍,以期为进一步了解和开展TCP现场评估提供参考。

Rapid on-site evaluation(ROSE)can provide timely feedback for the adequacy and effectiveness of fine needle aspiration biopsy(FNAB)tissues.It has been widely used in the sampling biopsy of thyroid,lymph node and other tissues.But the ROSE technique requires the presence of pathologists at the biopsy operation site,which limits its development in various hospitals.Telecytopathology(TCP)realizes the real-time communication between pathologists and biopsy operators by transmitting real time histopathological images,enabling to carry out the on-site evaluation without the presence of pathologists.At present,the TCP on-site evaluation has been widely carried out abroad,but there are few domestic researches.Therefore,this article reviewed the research progress of the application of TCP on-site evaluation in various pathological tissues,as well as the obstacles for widely conducting the TCP on-site evaluation,in order to provide references for further understanding and carrying out the TCP on-site evaluation.